T. Rowe Price Investment Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,476,948
| Closed | -$113M | – | 713 |
|
|
2025
Q1 | $113M | Sell |
1,476,948
-505,759
| -26% | -$38.6M | 0.07% | 257 |
|
|
2024
Q4 | $137M | Sell |
1,982,707
-294,436
| -13% | -$20.3M | 0.08% | 238 |
|
|
2024
Q3 | $166M | Sell |
2,277,143
-158,819
| -7% | -$11.6M | 0.1% | 211 |
|
|
2024
Q2 | $163M | Sell |
2,435,962
-1,015,618
| -29% | -$68M | 0.1% | 200 |
|
|
2024
Q1 | $93.6M | Sell |
3,451,580
-2,399,026
| -41% | -$65.1M | 0.06% | 297 |
|
|
2023
Q4 | $181M | Sell |
5,850,606
-2,474,278
| -30% | -$76.7M | 0.12% | 197 |
|
|
2023
Q3 | $210M | Buy |
8,324,884
+20,570
| +0.2% | +$519K | 0.15% | 169 |
|
|
2023
Q2 | $175M | Sell |
8,304,314
-111,116
| -1% | -$2.34M | 0.12% | 193 |
|
|
2023
Q1 | $143M | Buy |
8,415,430
+40,755
| +0.5% | +$695K | 0.1% | 203 |
|
|
2022
Q4 | $167M | Buy |
8,374,675
+307,913
| +4% | +$6.15M | 0.13% | 175 |
|
|
2022
Q3 | $174M | Buy |
+8,066,762
| New | +$174M | 0.14% | 158 |
|